13F data shows net sellers (1008) outnumber net buyers (910) with a $2.03B decrease in value. Insiders sold $2.55M over 90 days, zero buys, confidence score 0.0.

Confirmation

Further institutional outflow or an insider selling cluster would confirm the downtrend.

Invalidation Risk

A reversal of insider sentiment to buying or renewed institutional accumulation would invalidate this bearish view.

The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice and should not be used as the basis for any buy or sell decision.

Insider Trading (Form 4)

90d confidence

unique buyers

—

buy value

data as of 2026-07-16

12-Month Buy/Sell Activity

Feb 25

Feb 26

BuySell

操作	內部人	職稱	交易日	金額
賣出	Karsanbhai Surendralal Lanca	President & CEO	2026-03-10	$811K
賣出	LEVATICH MATTHEW S	Director	2026-02-10	$239K
賣出	Piazza Nicholas J.	Senior VP & CPO	2026-02-09	$1.07M
賣出	BLINN MARK A	Director	2026-02-05	$213K
賣出	BLINN MARK A	Director	2026-02-05	$226K
賣出	Karsanbhai Surendralal Lanca	President & CEO	2025-12-03	$966K
賣出	Train Michael H.	SVP & Chief Sustain Officer	2025-05-12	$3.38M
賣出	Karsanbhai Surendralal Lanca	President & CEO	2025-05-08	$1.89M

View all insider trades →

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding EMERSON ELECTRIC CO (EMR)?

Major stakeholders currently include BlackRock, Inc. ($5.5B), Vanguard Capital Management LLC ($4.8B), State Street CORP ($3.6B). Based on the latest 13F filings, there are a total of 2192 tracked investment funds and institutions maintaining positions in EMR.

What is the overall institutional sentiment toward EMR recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $2.0B, driven by 910 managers accumulating shares while 1008 reduced their exposure.

Which institutions have been selling or reducing their EMR positions?

In the latest period, 875 funds trimmed their holdings, and 133 managers completely exited their positions. The aggregate reported sell value was $27.9B.

Are there any notable investors adding EMR to their portfolios?

Yes, buying activity remains notable. 128 institutions opened new positions in {ticker}, and 782 existing holders added to their shares. The total reported buy value for the quarter amounted to $29.7B.